Abstract:Background Genetic, clinical and experimental evidence has mounted to suggest the implication of gut dysbiosis in the pathogenesis of ankylosing spondylitis (AS) through the gut-joint axis of inflammation[1]. A series of cross-sectional studies have unraveled the alterations of gut microbiome composition in patients with AS using metagenome sequencing. However, such observational associations might be limited to the small sample sizes and the influences from confounders. Furthermore, whether gut dysbiosis is a cause or a consequence of AS remains elusive. Mendelian randomization (MR) is an epidemiologic approach for causal inference using genetic variants as instrument variables. Objectives To assess the causal relationship between gut bacteria taxa and risk of AS using two-sample MR. Methods To select instrument variables for gut bacteria taxa, we filtered genome-wide significant (p ≤ 5 x 10-8) and independent (r 2 < 0.01 within the window size of 500kb) variants for 211 taxa from a large-scale genome-wide association study (GWAS) on gut microbiota which included 18,340 individuals from 24 cohorts[2]. The summary statistics on AS from the UK Biobank (UKB) and the FinnGen consortium were utilized for the discovery and replication analyses, respectively[3]. Under the framework of two-sample MR, the inverse variance weighted method or the Wald ratio method was used to assess the causal effect of gut microbial taxa on risk of AS. In addition, multiple sensitivity analyses and reverse MR analyses were conducted to validate the robustness of results and evaluate reverse causation, respectively. Results Despite no taxa passing the multiple-testing correction, six known taxa were identified to have causal effects on the onset of AS in the UKB cohort at the nominal significance level (p < 0.05). In the FinnGen cohort, only one bacterial genus, Anaerotruncus was replicated (UKB: βIVW = -0.0016, p = 0.04; FinnGen: βIVW = -0.3990, p = 0.04). Sensitivity analyses led no support to the presence of heterogeneity (Q_p > 0.05) and pleiotropy (Intercept_p > 0.05). Reverse MR analysis found no reverse causality from AS to Anaerotruncus. Conclusion Despite no current evidence supporting the association between Anaerotruncus and AS, this study provides the first genetic evidence for the protective effect of this short-chain fatty acid (SCFA)-producer against AS. Intriguingly, several studies have suggested a relationship between Anaerotruncus and immune-mediated diseases including rheumatoid arthritis and inflammatory bowel diseases[4]. These MR findings shed light on the causative microbiota and microbiome-modulating strategies for AS. References [1]Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol 2021;43:173–92. doi:10.1007/s00281-021-00845-0 [2]Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 2021;53:156–65. doi:10.1038/s41588-020-00763-1 [3]S S, M K, Y T, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 2021;53. doi:10.1038/s41588-021-00931-x [4]Thomann AK, Wüstenberg T, Wirbel J, et al. Depression and fatigue in active IBD from a microbiome perspective-a Bayesian approach to faecal metagenomics. BMC Med 2022;20:366. doi:10.1186/s12916-022-02550-7 Acknowledgements We thank the researchers in the MiBioGen consortium, UK Biobank and FinnGen biobanks for releasing their valuable GWAS datasets. Disclosure of Interests None Declared.

Causal effects of specific gut microbiota on musculoskeletal diseases: a bidirectional two-sample Mendelian randomization study

Causal effects of gut microbiota on the risk of osteomyelitis: a Mendelian randomization study

Assessment of the relationship between gut microbiota and bone mineral density: a two-sample Mendelian randomization study

Causal associations between human gut microbiota and osteomyelitis: a Mendelian randomization study

Causal associations between gut microbiota and synovitis–tenosynovitis: a two-sample Mendelian randomization study

The causal role of gut microbiota in development of osteoarthritis

Causal effects of specific gut microbiota on spinal stenosis diseases: a two-sample mendelian randomization study

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Causal Effects of Gut Microbiota on Scoliosis: A Bidirectional Two-Sample Mendelian Randomization Study

Causal association of gut microbiota on spondyloarthritis and its subtypes: a Mendelian randomization analysis

Basal metabolic rate mediates the causal relationship between gut microbiota and osteoarthritis: a two-step bidirectional Mendelian randomization study

Genetic association of gut microbiota with osteoarthritis: a multivariable Mendelian randomization study considering medication use

Causal effects of gut microbiota on multiple sclerosis: A two‐sample Mendelian randomization study

Causal relationship between gut microbiota and rheumatoid arthritis: a two-sample Mendelian randomisation study

Genetically supported causality between gut microbiota, gut metabolites and low back pain: a two-sample Mendelian randomization study

AB0089 MENDELIAN RANDOMIZATION REVEALS CAUSATIVE GUT BACTERIA FOR ANKYLOSING SPONDYLITIS

The causal relationship between gut microbiota and bone mineral density: a Mendelian randomization study

Genetically predicted causal effects of gut microbiota on spinal pain: a two-sample Mendelian randomization analysis

Gut microbiota and risk of ankylosing spondylitis

Assessing causal relationship from gut microbiota to heel bone mineral density

Causal Associations Between 141 Gut Microbiota Taxa and 14 Rheumatic Diseases: A Mendelian Randomization Study